Kane D, Greaney T, Shanahan M, Duffy G, Bresnihan B, Gibney R, FitzGerald O
Department of Rheumatology, St Vincent's University Hospital, Dublin 4, Ireland.
Rheumatology (Oxford). 2001 Sep;40(9):1002-8. doi: 10.1093/rheumatology/40.9.1002.
To compare ultrasonography with bone scintigraphy in the diagnosis of plantar fasciitis and to compare ultrasound-guided injection with palpation-guided injection in the management of idiopathic plantar fasciitis.
Twenty-three patients with a clinical diagnosis of idiopathic plantar fasciitis in 28 heels underwent ultrasonography and bone scintigraphy of both heels at baseline. The patients were randomized to ultrasound- or palpation-guided injection of triamcinolone hexacetonide and xylocaine into the plantar fascia. The 100 mm visual analogue scale (VAS) of pain, the heel tenderness index (HTI), and ultrasonography were performed at baseline and follow-up (mean=13.4 weeks).
The mean thickness (+/-standard error of the mean) of the plantar fascia, measured by ultrasonography, was 5.7+/-0.3 mm in symptomatic heels as compared with 3.8+/-0.2 mm in asymptomatic heels (P<0.001). Ultrasonography findings correlated with bone scintigraphic findings in the diagnosis of plantar fasciitis (P<0.001). Fourteen heels were randomized to ultrasound-guided injection, 10 heels were randomized to palpation-guided injection and four heels were not injected. Ultrasound- and palpation-guided injection resulted in significant mean improvements in VAS [39.6+/-9.2 (ultrasound) vs 41.5+/-8 (palpation)] and HTI [1.35+/-0.2 (ultrasound) vs 1.3+/-0.4 (palpation)]. There was no significant difference in the response rate following corticosteroid injection by either modality (ultrasound=13/14, palpation=8/10). Following injection, the mean thickness of the plantar fascia decreased from 5.7+/-0.3 mm to 4.65+/-0.4 mm (P<0.01).
Ultrasonography and bone scintigraphy are equally effective in the diagnosis of plantar fasciitis. Ultrasound-guided injection is effective in the management of plantar fasciitis but is not more effective than palpation-guided injection. Ultrasonography may be used as an objective measure of response to treatment in plantar fasciitis.
比较超声检查与骨闪烁显像在足底筋膜炎诊断中的应用,并比较超声引导下注射与触诊引导下注射在特发性足底筋膜炎治疗中的效果。
23例临床诊断为特发性足底筋膜炎的患者共28只足跟,在基线时对双侧足跟进行超声检查和骨闪烁显像。患者被随机分为超声引导或触诊引导下向足底筋膜注射己曲安奈德和利多卡因。在基线和随访时(平均13.4周)进行100mm视觉模拟疼痛评分(VAS)、足跟压痛指数(HTI)及超声检查。
超声测量显示,有症状足跟的足底筋膜平均厚度(±平均标准误差)为5.7±0.3mm,无症状足跟为3.8±0.2mm(P<0.001)。在足底筋膜炎的诊断中,超声检查结果与骨闪烁显像结果相关(P<0.001)。14只足跟被随机分配接受超声引导下注射,10只足跟被随机分配接受触诊引导下注射,4只足跟未注射。超声引导和触诊引导下注射均使VAS [39.6±9.2(超声)对41.5±8(触诊)]和HTI [1.35±0.2(超声)对l.3±0.4(触诊)]有显著的平均改善。两种方式的皮质类固醇注射有效率无显著差异(超声=13/14,触诊=8/10)。注射后,足底筋膜平均厚度从5.7±0.3mm降至4.65±0.4mm(P<0.01)。
超声检查和骨闪烁显像在足底筋膜炎诊断中同样有效。超声引导下注射在足底筋膜炎治疗中有效,但并不比触诊引导下注射更有效。超声检查可作为足底筋膜炎治疗反应的客观测量方法。